DK0859630T3 - Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer - Google Patents
Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancerInfo
- Publication number
- DK0859630T3 DK0859630T3 DK96935971T DK96935971T DK0859630T3 DK 0859630 T3 DK0859630 T3 DK 0859630T3 DK 96935971 T DK96935971 T DK 96935971T DK 96935971 T DK96935971 T DK 96935971T DK 0859630 T3 DK0859630 T3 DK 0859630T3
- Authority
- DK
- Denmark
- Prior art keywords
- combination
- thermozolomide
- treatment
- advanced cancer
- alpha ifn
- Prior art date
Links
- 201000011510 cancer Diseases 0.000 title abstract 2
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004964 temozolomide Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US623395P | 1995-10-04 | 1995-10-04 | |
| US62541096A | 1996-03-27 | 1996-03-27 | |
| PCT/US1996/015413 WO1997012630A1 (en) | 1995-10-04 | 1996-10-01 | Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0859630T3 true DK0859630T3 (da) | 2003-03-24 |
Family
ID=26675350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96935971T DK0859630T3 (da) | 1995-10-04 | 1996-10-01 | Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0859630B1 (da) |
| JP (2) | JP4156028B2 (da) |
| AT (1) | ATE229343T1 (da) |
| AU (1) | AU719074B2 (da) |
| CA (1) | CA2233544A1 (da) |
| DE (1) | DE69625373T2 (da) |
| DK (1) | DK0859630T3 (da) |
| ES (1) | ES2183977T3 (da) |
| PT (1) | PT859630E (da) |
| WO (1) | WO1997012630A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0009380A (pt) * | 1999-03-30 | 2001-12-26 | Schering Corp | Tratamento de câncer melhorado comtemozolomida |
| EP1908477A3 (en) * | 2000-01-24 | 2008-06-11 | Schering Corporation | Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| WO2001052882A1 (en) * | 2000-01-24 | 2001-07-26 | Schering Corporation | Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| EP1909822B1 (en) | 2005-06-29 | 2013-09-25 | Yeda Research And Development Co., Ltd. | Recombinant interferon alpha 2 (ifn alpha 2) mutants |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017371A (en) * | 1988-01-06 | 1991-05-21 | Amarillo Cell Culture Company, Incorporated | Method for reducing side effects of cancer therapy |
| EP0372809B1 (en) * | 1988-12-01 | 1993-08-04 | Schering Corporation | Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
| AU651998B2 (en) * | 1990-10-12 | 1994-08-11 | F. Hoffmann-La Roche Ag | Use of a retinoid |
| DE4244548C2 (de) * | 1992-12-30 | 1997-10-02 | Stockhausen Chem Fab Gmbh | Pulverförmige, unter Belastung wäßrige Flüssigkeiten sowie Blut absorbierende Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung in textilen Konstruktionen für die Körperhygiene |
-
1996
- 1996-10-01 EP EP96935971A patent/EP0859630B1/en not_active Expired - Lifetime
- 1996-10-01 PT PT96935971T patent/PT859630E/pt unknown
- 1996-10-01 CA CA002233544A patent/CA2233544A1/en not_active Abandoned
- 1996-10-01 DE DE69625373T patent/DE69625373T2/de not_active Expired - Lifetime
- 1996-10-01 JP JP51432197A patent/JP4156028B2/ja not_active Expired - Fee Related
- 1996-10-01 WO PCT/US1996/015413 patent/WO1997012630A1/en not_active Ceased
- 1996-10-01 AT AT96935971T patent/ATE229343T1/de active
- 1996-10-01 ES ES96935971T patent/ES2183977T3/es not_active Expired - Lifetime
- 1996-10-01 AU AU73731/96A patent/AU719074B2/en not_active Ceased
- 1996-10-01 DK DK96935971T patent/DK0859630T3/da active
-
2007
- 2007-03-26 JP JP2007080381A patent/JP2007169300A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997012630A1 (en) | 1997-04-10 |
| EP0859630A1 (en) | 1998-08-26 |
| PT859630E (pt) | 2003-02-28 |
| ES2183977T3 (es) | 2003-04-01 |
| JPH11514995A (ja) | 1999-12-21 |
| ATE229343T1 (de) | 2002-12-15 |
| AU7373196A (en) | 1997-04-28 |
| DE69625373D1 (de) | 2003-01-23 |
| JP2007169300A (ja) | 2007-07-05 |
| CA2233544A1 (en) | 1997-04-10 |
| EP0859630B1 (en) | 2002-12-11 |
| JP4156028B2 (ja) | 2008-09-24 |
| AU719074B2 (en) | 2000-05-04 |
| DE69625373T2 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950701350A (ko) | 부작용 감소와 동시에 인터페론을 이용한 질환의 치료방법 및 조성물(methods and compositions for the treatment of diseases with interferon while reducing side effects) | |
| DK0880350T3 (da) | Behandling af dissemineret sklerose | |
| IL134345A0 (en) | Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon | |
| DK254887A (da) | Salve til behandling af hudsygdomme | |
| ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
| DK0910428T3 (da) | Fotoferesebehandling af kroniske HCV-infektioner | |
| DE69629570D1 (de) | 3'utr des menschliches prohibitin-gens | |
| NO931413D0 (no) | Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer | |
| NO894222L (no) | Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder. | |
| DK0859630T3 (da) | Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer | |
| DK0858341T3 (da) | Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin | |
| ATE149840T1 (de) | Behandlung von leberkrebs | |
| KR950700737A (ko) | 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness) | |
| TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
| IT8809313A0 (it) | Macchina per il trattamento terapeutico di lombalgie e lombosciatalgie | |
| DK0869813T3 (da) | Anvendelse af beta-interferoner til behandling af restenose | |
| UA10928C2 (uk) | Спосіб профілактики гіперхолестериhемії | |
| DK1150981T3 (da) | Terapeutisk necleosidforbindelse | |
| IT9021051A0 (it) | "procedimento di estrzione e purificazione del gamma interferone umano ricombite" | |
| NO975554L (no) | Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon | |
| DE69118847D1 (de) | Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus | |
| DK169087D0 (da) | Praeparat til prophylakse og behandling af svinesygdomme | |
| MX9708885A (es) | Uso de ribavirin e interferon alfa para el tratamiento de hepatitis c. | |
| GEP19991514B (en) | Method for Treatment with Interferon | |
| MY119359A (en) | Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. |